INO vs SNA · $88.0M cap vs P/E 17, rev $1.33B
Inovio Pharmaceuticals Inc (INO) versus Snap-On Inc (SNA) — a side-by-side from cached financials, not a winner call.
Inovio Pharmaceuticals Inc (INO) is a biotechnology company listed on US.
Snap-On Inc (SNA) is a tools & accessories company listed on US.
Latest reported INO revenue for 2026-06-30 was $0. Net income was -$6.0M. INO currently screens at market cap $88.0M.
Latest reported SNA revenue for 2026-07-04 was $1.33B. Net income was $260.6M. Revenue was up 2.0% from 2026-04-04 to 2026-07-04. SNA currently screens at market cap $16.82B and trailing P/E 16.8.
INO currently screens at market cap $88.0M. SNA currently screens at market cap $16.82B and trailing P/E 16.8.
Not investment advice. Open the INO and SNA stock pages for the full models.
Not investment advice.